Swiss pharma company reveals SCOTUS appeal plans

22-09-2022

Staff Writer

Swiss pharma company reveals SCOTUS appeal plans

II.studio / Shutterstock.com

Federal Circuit denies petition to rehear dispute over multiple sclerosis medicine | Company will petition highest court over invalidity ruling.


Novartis, Federal Circuit, patent, patent infringement, HEC Pharm, Gilenya, generics, multiple sclerosis

LSIPR